Market Overview

Vascular Biogenics (NASDAQ: VBLT)

1.20 +0.02 (1.69%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
-0.12
219K



Q4 2019
Pre-Market
EPS:
REV:
-0.10
141K



Q3 2019
Pre-Market
EPS:
REV:
-0.15
101K



Q2 2019
Pre-Market
EPS:
REV:
-0.13
180K
-0.13
120K
-0.13
138K
0%
15%
Q1 2019
Pre-Market
EPS:
REV:
-0.24
163K
-0.12
1.15M
-0.12
219K
0%
-80.96%
Q4 2018
Pre-Market
EPS:
REV:
0.24
13.864M
-0.18
150K
-0.10
141K
-44.44%
-6%
Q3 2018
Pre-Market
EPS:
REV:
-0.24

300K
-0.15
101K

-66.33%
Q2 2018
Pre-Market
EPS:
REV:
-0.18
-0.18
300K
-0.13
180K
-27.78%
-40%
Q1 2018
Pre-Market
EPS:
REV:
-0.19
-0.20
150K
-0.24
163K
20%
8.67%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!